Akili Interactive Labs Inc, which is developing treatments and diagnostics for cognitive disorders, has raised an addition $11.9 million in its recent Series B financing, bringing the total tally to $42.4 million. The investors included M Ventures and Amgen Ventures.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: